![FY 2022 Q1 Could Be the Last Hurrah for the COVID Earnings Surge](https://www.g2intelligence.com/wp-content/uploads/2022/05/June22.LIR_.EarningsReports2022.Q1-iStock-1800x1250-1-1080x675.jpg)
FY 2022 Q1 Could Be the Last Hurrah for the COVID Earnings Surge
Most diagnostics companies experienced modest, flat, or negative top-line revenue growth rates in the first quarter of 2022.
Most diagnostics companies experienced modest, flat, or negative top-line revenue growth rates in the first quarter of 2022.
The IVDR will bring around 80 percent of in vitro diagnostic medical devices under the control of so-called Notified Bodies.
A research team has developed a new, simpler microfluidic chip that could make at-home diagnosis of diseases faster and more affordable
In CE-IVD-related announcements made over last week, the majority involved the cancer testing market.